# Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed Conditions

> **NCT01621763** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 68 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01621763
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2012-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01621763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01621763, "Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed Conditions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01621763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*